Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Friday.

Shares of Vail Resorts, Inc. MTN fell sharply in today's pre-market trading after the company reported weaker-than-expected results for its third quarter.

The company posted quarterly earnings of $9.54 per share, missing market estimates of $10.03 per share. The company’s sales came in at $1.28 billion versus expectations of $1.30 billion, according to data from Benzinga Pro.

Vail Resorts shares declined 6.8% to $180.77 in pre-market trading.

Here are some big stocks recording losses in today's pre-market trading session.

• Biomea Fusion, Inc. BMEA shares tumbled 59.2% to $4.60 in pre-market trading after the company received notice from the FDA that Its trials of BMF-219 have been placed on clinical hold.
• Latam Logistic Properties, S.A. LPA shares fell 16% to $39.60 in pre-market trading after jumping 49% on Thursday.
• Concrete Pumping Holdings, Inc. BBCP shares dipped 13% to $6.55 in pre-market trading after posting weaker-than-expected second-quarter results.
• FibroBiologics, Inc. FBLG shares fell 8.1% to $9.48 in pre-market trading. FibroBiologics shares jumped around 54% on Thursday after the company in a FormRW disclosed that its Registration Statement has not been declared effective by the SEC and no securities have been issued or sold under the Registration Statement.
• Eastern Bankshares, Inc. EBC shares fell 7.7% to $12.25 in pre-market trading.
• DocuSign, Inc. DOCU shares declined 7.1% to $50.70 in pre-market trading. DocuSign reported better-than-expected earnings for its first quarter and the company’s board also authorized a $1 billion increase to its existing stock repurchase program. The company said it sees second-quarter billings in the range of $715 million to $725 million.
• Samsara Inc. IOT shares declined 6.2% to $32.69 in pre-market trading after the company reported first-quarter earnings.
• Fitell Corporation FTEL shares fell 5.3% to $15.14 in pre-market trading.
• Replimune Group, Inc. REPL shares fell 5.2% to $6.74 in pre-market trading. Replimune Group shares jumped around 28% on Thursday after the company announced the topline results from the primary analysis of the IGNYTE clinical trial of RP1 plus nivolumab in anti-PD1 failed melanoma.

Now Read This: Fear & Greed Index In ‘Neutral’ Zone Ahead Of Jobs Report; Dow Settles Higher

Don't forget to check out our premarket coverage here